Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

194 public trials 80 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Enrolling by Invitation

VEN+IDAC vs IDAC in AML

NCT07537257

Conditions: AML (Acute Myelogenous Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Department of Hematology, Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

NCT07720843

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients

NCT07709585

Conditions: Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 L858R Mutation, +6 more
Locations: Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia

NCT07690891

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry

NCT07691034

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy

NCT07670962

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant

NCT07572929

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +14 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas

NCT07514715

Conditions: Aggressive B-cell Lymphomas, Neoplasm, Residual, Neoplasms, +3 more
Locations: CHU D'AMIENS - HOPITAL SUD - Service Hématologie Clinique et Thérapie Cellulaire Amiens, France

CHU D'ANGERS - Service des Maladies du Sang Angers, France

CH D'AVIGNON - HOPITAL HENRI DUFFAUT - Service d'Onco-Hématologie Avignon, France

CHU JEAN MINJOZ - Service Hématologie Besançon, France

View all 30 locations

View Trial Details

Not Yet Recruiting

ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)

NCT07597252

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations: Linkou Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

NCT07517705

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Fred & Pamela Buffet Cancer Center Omaha, Nebraska, United States

View Trial Details

Neoplasm, Residual

Neoplasm, Residual trial results

Related conditions